Characterization of the human cysteinyl leukotriene CysLT1 receptor KR Lynch, GP O'Neill, Q Liu, DS Im, N Sawyer, KM Metters, N Coulombe, ... Nature 399 (6738), 789-793, 1999 | 1184 | 1999 |
The Concise Guide to PHARMACOLOGY 2021/22: Introduction and other protein targets SPH Alexander, E Kelly, A Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 178, S1-S26, 2021 | 237 | 2021 |
Regulator of G-protein signaling (RGS) proteins in cancer biology JH Hurst, SB Hooks Biochemical pharmacology 78 (10), 1289-1297, 2009 | 178 | 2009 |
RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activity of Gi family G-proteins with differential selectivity and maximal activity SB Hooks, GL Waldo, J Corbitt, ET Bodor, AM Krumins, TK Harden Journal of Biological Chemistry 278 (12), 10087-10093, 2003 | 178 | 2003 |
Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent SB Hooks, WL Santos, DS Im, CE Heise, TL Macdonald, KR Lynch Journal of Biological Chemistry 276 (7), 4611-4621, 2001 | 164 | 2001 |
Microglia Phenotypes in Aging and Neurodegenerative Diseases MY Wendimu, SB Hooks Cells 11 (13), 2091, 2022 | 136 | 2022 |
Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance E Cacan, MW Ali, NH Boyd, SB Hooks, SF Greer PloS one 9 (1), e87455, 2014 | 116 | 2014 |
Regulator of G-protein signalling expression and function in ovarian cancer cell lines JH Hurst, N Mendpara, SB Hooks Cellular & molecular biology letters 14 (1), 153-174, 2009 | 109 | 2009 |
Role of Ca 2+-independent phospholipase A 2 in cell growth and signaling SB Hooks, BS Cummings Biochemical pharmacology 76 (9), 1059-1067, 2008 | 104 | 2008 |
Purification and functional reconstitution of the human P2Y12 receptor ET Bodor, GL Waldo, SB Hooks, J Corbitt, JL Boyer, TK Harden Molecular pharmacology 64 (5), 1210-1216, 2003 | 104 | 2003 |
Identification of a novel human phosphatidic acid phosphatase type 2 isoform SB Hooks, SP Ragan, KR Lynch FEBS letters 427 (2), 188-192, 1998 | 102 | 1998 |
Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells SB Hooks, P Callihan, MK Altman, JH Hurst, MW Ali, MM Murph Molecular cancer 9, 1-15, 2010 | 99 | 2010 |
A role of RGS proteins in drug addiction SB Hooks, K Martemyanov, V Zachariou Biochemical pharmacology 75 (1), 76-84, 2008 | 78 | 2008 |
The Gβγ dimer as a novel source of selectivity in G-protein signaling: GGL-ing at convention MB Jones, DP Siderovski, SB Hooks Molecular interventions 4 (4), 200, 2004 | 71 | 2004 |
Characterization of a receptor subtype-selective lysophosphatidic acid mimetic SB Hooks, SP Ragan, DW Hopper, CW Hönemann, ME Durieux, ... Molecular pharmacology 53 (2), 188-194, 1998 | 65 | 1998 |
Interleukin‐1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel‐associated acute pain syndrome X Yan, F Li, DW Maixner, R Yadav, M Gao, MW Ali, SB Hooks, HR Weng Glia 67 (3), 482-497, 2019 | 64 | 2019 |
Regulation of stem cell pluripotency and differentiation by G protein coupled receptors P Callihan, J Mumaw, DW Machacek, SL Stice, SB Hooks Pharmacology & therapeutics 129 (3), 290-306, 2011 | 60 | 2011 |
Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells MW Ali, E Cacan, Y Liu, JY Pierce, WT Creasman, MM Murph, ... PloS one 8 (3), e60185, 2013 | 58 | 2013 |
Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology JH Hurst, J Mumaw, DW Machacek, C Sturkie, P Callihan, SL Stice, ... BMC neuroscience 9 (1), 118, 2008 | 49 | 2008 |
The concise guide to PHARMACOLOGY 2023/24: introduction and other protein targets SPH Alexander, E Kelly, AA Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 180, S1-S22, 2023 | 44 | 2023 |